Compare CHE & ONTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHE | ONTO |
|---|---|---|
| Founded | 1970 | 1940 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 6.6B |
| IPO Year | N/A | N/A |
| Metric | CHE | ONTO |
|---|---|---|
| Price | $457.76 | $215.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $574.25 | $168.75 |
| AVG Volume (30 Days) | 133.4K | ★ 693.7K |
| Earning Date | 02-25-2026 | 02-05-2026 |
| Dividend Yield | ★ 0.53% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 18.95 | 3.55 |
| Revenue | ★ $2,530,634,000.00 | $1,002,336,000.00 |
| Revenue This Year | $5.91 | $3.72 |
| Revenue Next Year | $6.21 | $17.29 |
| P/E Ratio | ★ $23.84 | $56.95 |
| Revenue Growth | ★ 6.45 | 6.38 |
| 52 Week Low | $408.42 | $85.88 |
| 52 Week High | $623.61 | $228.42 |
| Indicator | CHE | ONTO |
|---|---|---|
| Relative Strength Index (RSI) | 67.63 | 81.50 |
| Support Level | $438.87 | $176.00 |
| Resistance Level | $452.39 | $188.07 |
| Average True Range (ATR) | 9.83 | 7.10 |
| MACD | 2.42 | 3.69 |
| Stochastic Oscillator | 95.32 | 84.12 |
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.